HPV Testing & Pap Test Market size is $1,542.3 in 2019, growing at a CAGR of 6.1% during the forecast period 2020-2025. The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. HPV is a sexually transmitted virus which is the primary reason for causing cervical cancer. Pap test checks the cervix for any cells that are not normal. The cervix is the lower part of the uterus (womb), which opens into the vagina. Abnormal cervical cells, if not found and treated can lead to cervical cancer. Approximately, 90% of deaths from cervical cancer occur in middle- to low-income countries. The growing number of cervical cancer cases results in the need for new, technically advanced, and less expensive screening programs.

Key Takeaways

Increasing awareness amongst people for early treatment is set to propel the growth of the market.

Rising healthcare expenditure is the driving factors for the growth of HPV Testing & Pap Test market.

The increased awareness pertaining to the screening programs of cervical cancer drives the market’s growth.

Europe region is estimated to record the fastest growth rate during the forecast period.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=508535

By Application - Segment Analysis

In 2019, Cervical Cancer Screening segment dominated the HPV Testing & Pap Test Market in terms of revenue is estimated to grow at a CAGR of 4.3% owing towards the increasing awareness about the benefits associated with the early detection of cancer and the growing government support towards controlling the incidence rate of late-stage cervical cancer. Cervical cancer screening is done to identify precancerous lesions caused by HPV so they can be removed to prevent invasive cancers from developing. According to WHO Cervical cancer is the fourth most common cancer in women. In 2018, an estimated 5,70,000 women were diagnosed with cervical cancer worldwide and about 3,11,000 women died from the disease abetting towards the market’s growth.

Drivers – HPV Testing & Pap Test Market

Increasing In The Prevalence Of Cancer

Increasing awareness level among people regarding the availability of various treatment options for HPV Testing & Pap Test management is anticipated to impel the demand. Rising healthcare expenditure in developing economies coupled with inclination towards opting advanced stage cancer drugs is anticipated to boost market growth. Increasing number of cervical cancer cases, growing aging population are propelling the growth of the HPV testing and Pap test market. National program on prevention and management of cancer by Government is the other major factor driving growth.

HPV Testing & Pap Test Industry Outlook

Product Launches was the key strategy of the players in the HPV Testing & Pap Test Industry. HPV Testing & Pap Test top 10 companies include Abbott Laboratories, Qiagen N. V., Becton, Dickinson and Company, Quest Diagnostics, Hologic Inc., Roche, Arbor Vita Corporation, Femasys Inc., Onco Health Corporation, Smith & Nephew and Seegene Inc.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.